Periodic Transaction Report
| Asset | Ticker | Category | Type | Transaction Date | Amount |
|---|---|---|---|---|---|
| Pharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001. | PRIVATE EQUITY | Purchase | Nov. 27, 2017 | $50,001 - $100,000 |